https://www.biospace.com/article/merck-s-davis-scouring-for-deals-in-preparation-for-keytruda-patent-cliff-/#:~:text=Merck’s%20blockbuster%20cancer%20drug%20Keytruda%20has%20been%20called,Merck’s%20patent%20exclusivity%20on%20Keytruda%20expires%20in%202028.
Worth a gander > Time is on Mercks side in the absence of extraordinary efti data
Overnight Market report, page-665
-
- There are more pages in this discussion • 2,172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.270M | 3.611M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 286261 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 253490 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |